This study aimed to improve the quality of life for people living with asthma by testing a new biologic treatment for severe asthma.
Researchers were working to demonstrate that this treatment, with reduced dosing frequency, was equivalent to the currently approved biologic drugs approved for asthma.
End date: 31st July 2024
Link to study on clinicaltrials.gov